INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹403 Cr | ₹394 Cr | ₹18 Cr | ₹25 Cr |
What is the latest Total Debt ratio of INDEGENE ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹403 Cr |
| Mar2023 | ₹394 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹25 Cr |
How is Total Debt of INDEGENE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹403 Cr | 2.23 | |
| Mar2023 | ₹394 Cr | 2,061.97 | |
| Mar2022 | ₹18 Cr | -26.35 | |
| Mar2021 | ₹25 Cr | - | |
Compare Total Debt of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,318.7 Cr | -5.2% | -9.3% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -5.2% |
-9.3% |
-17.1% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses